1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Autoimmune Drug Focus MARCH 2016

Autoimmune Drug Focus MARCH 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Merck KGaA Trial Highlights Growing Potential Biosimilar Adalimumab Market
Industry Trend Analysis - Collaboration Holds Potential To Stem Declining Diabetes Sales
Industry Brief - Biocon Enters Insulin Agreement With Lab PiSA
Industry Brief - FDA Accepts Allergan's Rifaximin ANDA For Filing
Industry Trend Analysis - Lupin On Course To Cement Place In US Market
Industry Brief - TiGenix Submits EU MAA For Cx601
Industry Brief - TiGenix' Cx601 Shows Promising Results In Phase III Admire-CD Trial
Industry Brief - Tofacitinib Yields Promising Results In Pivotal Phase III OCTAVE Trials
Industry Brief - Opexa Initiates Restructuring To Focus Use Of Resources
Industry Trend Analysis - Narrowing Trials Reduces Expenditure But Increases Risks For Arzerra
Industry Brief - MHLW Lifts All-Case Surveillance Condition For Humira Approval
Industry Brief - MTP/Janssen Amend Simponi Marketing Agreement
Industry Brief - Sarilumab Superior Over Adalimumab In Phase III Active RA Study
Industry Brief - Can-Fite Submits CF101 Phase III Protocol Design To EMA For Treating RA
Industry Brief - CHMP Recommends Ixekizumab To Treat Moderate-to-Severe Plaque Psoriasis
Industry Trend Analysis - AstraZeneca/Boehringer Ingelheim Tie Will Create Strong Development/Marketing Platform
Industry Brief - FDA Accepts Amgen's sBLA For Expanded Use Of Enbrel
Industry Brief - Scientific Approval For LEO Pharma's Enstilar To Treat Psoriasis In EU
Industry Brief - EMA ODD For TNT009 To Treat Cold Agglutinin Disease
Industry Brief - Fostamatinib Phase II Trial Initiated In AIHA
Industry Trend Analysis - Diagnostic Advances To Unlock New SLE Treatment Avenues
Industry Brief - FDA Fast Track Designation For Aurinia's Voclosporin For LN
Industry Brief - GSK Reports Publication Of Benlysta Long-Term Analysis In SLE
Industry Brief - Corbus Initiates Resunab Phase II Trial In SLE
Industry Brief - FDA ODD For AstraZeneca's MEDI-551 To Treat NMO/NMOSD
Industry Brief - First Patients Dosed In Xencor's XmAb5871 Phase II IgG4-RD/SLE Trials
Industry Brief - Evotec Earns Preclinical Milestone In Collaboration With Padlock
Industry Brief - Chugai Secures Japanese ODD For Tocilizumab To Treat Systemic Scleroderma
Industry Brief - hCDR1 Phase II Trial Design Completed In SLE
Industry Brief - ImmunogenX Completes Alvine's Non-Cash Assets Takeover
Industry Brief - Autoimmune Conferences - June 2016

Table Of Contents

Autoimmune Drug Focus MARCH 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in the US

  • February 2017
    9 pages
  • Anti-Infective  

    Influenza  

  • United States  

View report >

Therapy Market in Sweden

  • February 2017
    8 pages
  • Therapy  

    Hormone  

    Antidiabetics  

  • Sweden  

View report >

Contraceptive Market in the Netherlands

  • February 2017
    8 pages
  • Contraceptive  

  • Netherlands  

View report >

Diabetes Statistics

5 days ago

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.